References
- Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma. Am J Clin Oncol 1991; 14: 478-482. https://doi.org/10.1097/00000421-199112000-00004
- Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annal Oncol 2007; 18: 149-157.
- Chamberlain MC, Nolan C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol 2005; 75: 71-83. https://doi.org/10.1007/s11060-004-8100-y
- Chowdhary S, Chamberlain M. Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Canc Netw 2005; 3: 693-703. https://doi.org/10.6004/jnccn.2005.0039
- Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. Annal Oncol 2002; 13: 1099-1107. https://doi.org/10.1093/annonc/mdf175
- Malik R, Gabor LJ, Foster SF, McCorkell BE, Canfield PJ. Therapy for Australian cats with lymphosarcoma. Aust Vet J 2001; 79: 808-817. https://doi.org/10.1111/j.1751-0813.2001.tb10923.x
- Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The massachusetts general hospital experience 1958-1989. Cancer 1994; 74: 1383-1397. https://doi.org/10.1002/1097-0142(19940815)74:4<1383::AID-CNCR2820740432>3.0.CO;2-1
- Moore AS, Cotter SM, Frimberger AE, Wood CA, Rand WM, L'Heureux DA. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. J Vet Int Med 1996; 10: 372-375. https://doi.org/10.1111/j.1939-1676.1996.tb02083.x
- Seo KW, Choi US, Lee JB, Kim MI, Oh YI, Chung JY, Lee SK, Hwang CY, Youn HY. Central nervous system relapses in 3 dogs with B-cell lymphoma. Can Vet J 2011; 52: 778-783.
- Snyder JM, Lipitz L, Skorupski KA, Shofer FS, Van Winkle TJ. Secondary intracranial neoplasia in the dog: 177 cases (1986-2003). J Vet Int Med 2008; 22: 172-177. https://doi.org/10.1111/j.1939-1676.2007.0002.x
- Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Secondary central nervous system lymphoma. Int J Hematol 2006; 84: 128-135. https://doi.org/10.1532/IJH97.06091
- Troxel MT, Vite CH, Massicotte C, McLear RC, Van Winkle TJ, Glass EN, Tiches D, Dayrell-Hart B. Magnetic resonance imaging features of feline intracranial neoplasia: retrospective analysis of 46 cats. J Vet Int Med 2004; 18: 176-189. https://doi.org/10.1111/j.1939-1676.2004.tb00158.x
- Troxel MT, Vite CH, Winkle TJ, Newton AL, Tiches D, Dayrell-Hart B, et al. Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001). J Vet Int Med 2003; 17: 850-859.
- van Besien K, Ha CS, Murphy S, McLaughlin P, Rodriguez A, Amin K, Forman A, Romaguera J, Hagemeister F, Younes A, Bachier C, Sarris A, Sobocinski KS, Cox JD, Cabaillas F. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 1998; 91: 1178-1184.
- Withrow S, Vail DM, Page RL. Feline Lymphoma and Leukemia. In:Withrow and MacEwen's Small animal clinical oncology. 5th ed. St. Louis: Elsevier Health Sciences 2013; 638-653.
- Zaki FA, Hurvitz AI. Spontaneous neoplasms of the central nervous system of the cat. J Small Anim Pract 1976; 17: 773-782. https://doi.org/10.1111/j.1748-5827.1976.tb06943.x